Too many lung cancer patients don't get all the biomarker testing they should have before beginning treatment. Dr. Adam Fox wants to change that.

The Blood and Bone Marrow Transplant team recently celebrated 3,000 transplants – and patient Kennedy Golden exemplifies why they do what they do.

A Hollings immunologist will use an American Cancer Society Research Scholar Grant to study ways to make colorectal cancer more susceptible to immunotherapy.

An MUSC Hollings Cancer Center team describes how the bacteria Porphyromonas gingivalis connects to chemotherapy resistance.

Sarah Harry may be retired but she is one busy woman: caregiving, church activities - and chemotherapy for herself.

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.

A new study from Hollings researchers suggests a dual approach for targeting pancreatic cancer.

Members of the Hollings and MUSC community enthusiastically support Dragon Boat Charleston every year.

A new dedicated phase I clinical trials unit at Hollings means more and different types of clinical trials will be available to cancer patients.

A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.